左奥硝唑、奥硝唑、替硝唑治疗盆腔炎临床对比研究  

A comparative study on the efficacy of levornidazole,ornidazole, tinidazole in the treatment for pelvic inflammatory disease

作　　者：郝玉凤[1] 王茜[1] 袁晓洁[1] 王丽萍[1] 卢战凯[1] 

机构地区：[1]齐齐哈尔医学院第五附属医院(大庆龙南医院),黑龙江大庆163453

出　　处：《中国性科学》2012年第8期38-39,共2页Chinese Journal of Human Sexuality

摘　　要：目的:研究不同用药方案治疗盆腔炎的疗效和副反应,为患者提供经济有效的治疗手段。方法:将90例盆腔炎患者随机分成左奥硝唑组、奥硝唑组和替硝唑组,分别给药,观察患者的症状、体征及实验室指标。结果:从治疗效果上左奥硝唑与奥硝唑差异无显著性,左奥硝唑及奥硝唑与替硝唑组差异有显著性;从药物副作用上左奥硝唑组与奥硝唑组、替硝唑组差异有显著性。结论:左奥硝唑及奥硝唑在治疗效果上要优于替硝唑,但是在药物的副作用上,左奥硝唑要优于奥硝唑及替硝唑。Objectives： To study the efficacy and adverse effect of different drugs in the treatment for pelvic inflammatory disease in order to provide patients with a cost - effective treatment. Methods： Ninety patients with pelvic inflammatory disease were randomly divided into three groups, namely, Levoruidazole group, ornidazole group and tinidazole group. We observed and recorded the symptoms and signs of patients and the related laboratory indexes. Results ： In terms of efficacy, levoruidazole had no significant difference from omidazole, but had significant difference from tinidazole. With regards to adverse effect, there was significant difference between levoruidazole and the other two drug groups. Conclusion： Levoruidazole and ornidazole had a better efficacy than tinidazole. Levoruidazole had the least adverse effect.

关 键 词：左奥硝唑 奥硝唑 替硝唑 盆腔炎 

分 类 号：R978.61[医药卫生—药品]